Table 2.
Cox regression analysis of parameters associated with survival.
| Variables | RFS | OS | ||
|---|---|---|---|---|
| HR (95% CI) | p Value | HR (95% CI) | p Value | |
| Age, ≤65 vs. >65 | 0.84 (0.49–1.43) | 0.517 | 0.86 (0.45–1.67) | 0.663 |
| Gender, Male vs. Female | 0.55 (0.31–1.19) | 0.145 | 0.68 (0.34–1.35) | 0.265 |
| PS, 0–1 vs. 2–3 | 0.63 (0.36–1.08) | 0.090 | 0.64 (0.33–1.33) | 0.183 |
| Differentiation, W/MD vs. PD/SRC | 0.55 (0.30–1.03) | 0.062 | 0.75 (0.37–1.52) | 0.424 |
| Stage II vs. III | 0.03 (0.01–0.27) | 0.003 | 0.03 (0.01–0.63) | 0.024 |
| LNR, ≤0.21 vs. >0.21 | 0.47 (0.27–0.82) | 0.008 | 0.37 (0.19–0.75) | 0.005 |
| Regimen, S1 vs. doublet | 0.78 (0.45–1.33) | 0.360 | 0.72 (0.37–1.37) | 0.313 |
RFS–recurrence-free survival, OS–overall survival, W/MD–well/moderate differentiation, PD/SRC–poorly differentiation/signet ring cell, LNR–lymph node ratio, HR–hazard ratio, CI–confidence interval.